These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 37619557)
1. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF- Hayton C; Ahmed W; Cunningham P; Piper-Hanley K; Pearmain L; Chaudhuri N; Leonard C; Blaikley JF; Fowler SJ J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37619557 [TBL] [Abstract][Full Text] [Related]
2. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects. Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041 [TBL] [Abstract][Full Text] [Related]
3. Volatile metabolites differentiate air-liquid interface cultures after infection with Ahmed W; Bardin E; Davis MD; Sermet-Gaudelus I; Grassin Delyle S; Fowler SJ Analyst; 2023 Jan; 148(3):618-627. PubMed ID: 36597770 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β Togami K; Yamaguchi K; Chono S; Tada H J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823 [TBL] [Abstract][Full Text] [Related]
5. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath. Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700 [TBL] [Abstract][Full Text] [Related]
6. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice. Guan S; Liu H; Zhou J; Zhang Q; Bi H Toxicol Lett; 2022 Jun; 363():45-54. PubMed ID: 35472619 [TBL] [Abstract][Full Text] [Related]
7. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study. Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338 [TBL] [Abstract][Full Text] [Related]
9. Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis. Machahua C; Vicens-Zygmunt V; Ríos-Martín J; Llatjós R; Escobar-Campuzano I; Molina-Molina M; Montes-Worboys A Exp Lung Res; 2022 Apr; 48(3):126-136. PubMed ID: 35594338 [No Abstract] [Full Text] [Related]
10. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
11. Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry. Gerritsen MG; Brinkman P; Escobar N; Bos LD; de Heer K; Meijer M; Janssen HG; de Cock H; Wösten HAB; Visser CE; van Oers MHJ; Sterk PJ Med Mycol; 2018 Feb; 56(2):253-256. PubMed ID: 28525576 [TBL] [Abstract][Full Text] [Related]
12. MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway. Ballester B; Milara J; Montero P; Cortijo J Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204432 [TBL] [Abstract][Full Text] [Related]
13. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling. Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348 [TBL] [Abstract][Full Text] [Related]
14. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489 [TBL] [Abstract][Full Text] [Related]
15. Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures. Baranska A; Smolinska A; Boots AW; Dallinga JW; van Schooten FJ J Breath Res; 2015 Oct; 9(4):047102. PubMed ID: 26469548 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Qian W; Cai X; Qian Q; Zhang W; Wang D J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947 [TBL] [Abstract][Full Text] [Related]
17. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts. Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803 [TBL] [Abstract][Full Text] [Related]
18. Volatile organic compound signature from co-culture of lung epithelial cell line with Pseudomonas aeruginosa. Lawal O; Knobel H; Weda H; Bos LD; Nijsen TME; Goodacre R; Fowler SJ Analyst; 2018 Jul; 143(13):3148-3155. PubMed ID: 29878008 [TBL] [Abstract][Full Text] [Related]